what is glp 1/gip The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Frontiers | Clinical perspectives on

The multidisciplinary team of GI providers, gut-brain specialists, and registered dietitians at Oshi Health can offer a tailored treatment plan to help you implement the lifestyle and behavioral adjustments needed to reduce GI side effects associated with GLP-1 drugs

Animal models of AD, PD, ischemic stroke, ICH, HD, MS, ALS, depression, epilepsy, and SCI have all shown benefits following GLP-1 receptor agonist treatment

This is a practitioner only medicine

Some eligible studies have demonstrated the action of caffeine on glial cells through changes in GFAP and Iba-1 expression in stress-specific brain areas [27, 29]

Weekly self-injection under the skin (subcutaneous) Gradual dose increase to minimize side effects Regular follow-ups to monitor progress and adjust treatment Support with nutrition and lifestyle coaching Common Side Effects Nausea Diarrhea or constipation Mild stomach discomfort Side effects usually lessen after the first few weeks

doi: 10.3389/fphys.2021.715506 125 TanJ.McKenzieC.PotamitisM.ThorburnA